Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Becotide 100 inhaler
0302000C0BCAHAB
|
Becotide | Beclometasone dipropionate | Respiratory System | No data available |
|
Becotide 100microgram Rotacaps
0302000C0BCACAE
|
Becotide | Beclometasone dipropionate | Respiratory System | No data available |
|
Becotide 200 inhaler
0302000C0BCAQAR
|
Becotide | Beclometasone dipropionate | Respiratory System | No data available |
|
Becotide 200microgram Rotacaps
0302000C0BCADAF
|
Becotide | Beclometasone dipropionate | Respiratory System | No data available |
|
Becotide 400microgram Rotacaps
0302000C0BCAGAI
|
Becotide | Beclometasone dipropionate | Respiratory System | No data available |
|
Becotide 50 inhaler
0302000C0BCAIAA
|
Becotide | Beclometasone dipropionate | Respiratory System | No data available |
|
Care Hayfever Relief 50micrograms/dose nasal spray
1202010C0BJAAAA
|
Care Hayfever Relief | Beclometasone dipropionate | Ear, Nose and Oropharynx | No data available |
|
Filair 100 inhaler
0302000C0BGABAB
|
Filair | Beclometasone dipropionate | Respiratory System | No data available |
|
Filair 50 inhaler
0302000C0BGAAAA
|
Filair | Beclometasone dipropionate | Respiratory System | No data available |
|
Filair Forte 250micrograms/dose inhaler
0302000C0BGACAC
|
Filair | Beclometasone dipropionate | Respiratory System | No data available |
|
Numark Hayfever Relief 50micrograms/dose nasal spray
1202010C0BNAAAA
|
Numark Hayfever Relief | Beclometasone dipropionate | Ear, Nose and Oropharynx | No data available |
|
Propaderm 0.025% cream
1304000C0BBAAAA
|
Propaderm | Beclometasone dipropionate | Skin | No data available |
|
Propaderm 0.025% ointment
1304000C0BBAEBA
|
Propaderm | Beclometasone dipropionate | Skin | No data available |
|
Proxor 200micrograms/dose / 6micrograms/dose inhaler
0302000C0BYABBZ
|
Proxor (old) | Beclometasone dipropionate | Respiratory System | No data available |
|
Pulvinal Beclometasone Diprop 100microg/dose dry pdr inh
0302000C0BLABBJ
|
Pulvinal beclometasone | Beclometasone dipropionate | Respiratory System | No data available |
|
Pulvinal Beclometasone Diprop 200microg/dose dry pdr inh
0302000C0BLAABU
|
Pulvinal beclometasone | Beclometasone dipropionate | Respiratory System | No data available |
|
Pulvinal Beclometasone Diprop 400microg/dose dry pdr inh
0302000C0BLACBS
|
Pulvinal beclometasone | Beclometasone dipropionate | Respiratory System | No data available |
|
Rino Clenil 50micrograms/dose nasal spray
1202010C0BLAAAA
|
Rino Clenil | Beclometasone dipropionate | Ear, Nose and Oropharynx | No data available |
|
Salbutamol 100microg/dose / Beclometasone 50microg/dose inh
0302000C0AAANAN
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | No data available |
|
Salbutamol 200microg/Beclometasone 100microg pdr caps
0302000C0AABLBL
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | No data available |
|
Salbutamol 400microg/Beclometasone 200microg pdr caps
0302000C0AAAPAP
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | No data available |
|
Ventide inhaler
0302000C0BDAAAN
|
Ventide | Beclometasone dipropionate | Respiratory System | No data available |
|
Ventide Paediatric Rotacaps
0302000C0BDACBL
|
Ventide | Beclometasone dipropionate | Respiratory System | No data available |
|
Ventide Rotacaps
0302000C0BDABAP
|
Ventide | Beclometasone dipropionate | Respiratory System | No data available |
|
Vivabec 50micrograms/dose nasal spray
1202010C0BIAAAA
|
Vivabec | Beclometasone dipropionate | Ear, Nose and Oropharynx | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.